- Advertisement -
- Advertisement -

Swedish Hedge Funds Among Institutional Investors in Immunicum Directed Share Issue

- Advertisement -

Stockholm (HedgeNordic) – Immunicum, a Swedish company said to be creating the blue print for the world’s first personalized, off-the-shelf affordable cancer treatment, has decided to implement a directed issue of approximately SEK 178 million and a rights issue of approximately SEK 173 million, according to a press release.

The money to be raised is aimed at continuing to finance the clinical development of the company´s immunotherapeutical drug ilixadencel.

Several institutions are among the investors subscribing to the directed issue including three Swedish hedge fund companies; Gladiator, Nordic Cross, and Adrigo. Other institutions include AP2, AP4, and Alfred Berg.

Photo by Louis Reed on Unsplash.


Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by the HedgeNordic editorial team.


Most Popular This Week


Request for Proposal

- Advertisement -

Latest Articles

RFP: Absolute Return Multi-Strategy/Fund of Funds

(Global Fund Search) - A Danish Institutional Investor is searching for an absolute return strategy for an allocation of EUR 40 million. The mandate...

Brummer Multi-Strategy Navigates 2022’s “Perfect” Storm

Stockholm (HedgeNordic) – 2022 experienced a “perfect” inflation storm due to an unprecedented amount of monetary and fiscal policy stimulus during the pandemic, war,...

Dream Comes True for Grönblom

Stockholm (HedgeNordic) – Ernst Grönblom had been running his high-conviction strategy of cherry-picking the stock market’s undervalued future winners under the umbrella of United...

Boarding the Broader Alternatives Ship

Stockholm (HedgeNordic) – Tore Davidsen, portfolio manager of SEB Eureka Fixed Income Relative Value since its launch in 2018, will join BankInvest as Senior...

Year of Stabilization of Interest Rates

By Kari Vatanen, CIO of Veritas: The year 2022 was a year of negative surprises in the investment markets and in the global economy. Hopes...

Playing Offense in the Net-Zero Transition

Stockholm (HedgeNordic) – The world’s adoption of cleaner energy had been ongoing prior to Russia unleashing war in Ukraine. The war and its consequences...